Cargando…
Changes in PBM Business Practices in 2019: True Innovation or More of the Same?
In 2019, pharmacy benefit managers (PBMs) responded to intense public criticism with business model changes described as movements toward full transparency and innovation to reduce costs for benefit plan sponsors. We critically analyze these changes in light of key challenges in specialty drug manag...
Autores principales: | Motheral, Brenda R., Fairman, Kathleen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391101/ https://www.ncbi.nlm.nih.gov/pubmed/32869706 http://dx.doi.org/10.18553/jmcp.2020.20213 |
Ejemplares similares
-
Do Decision-Analytic Models Identify Cost-Effective Treatments? A Retrospective Look at Helicobacter Pylori Eradication
por: Fairman, Kathleen A., et al.
Publicado: (2003) -
PBM: Now more than ever necessary()
por: García-Erce, J.A., et al.
Publicado: (2022) -
The Entry Lag of Innovative Drugs in Russia, 2010–2019
por: Chaplenko, Alexander, et al.
Publicado: (2021) -
An Ethical Analysis of Pharmacy Benefit Manager (PBM) Practices
por: Drettwan, Jacob J., et al.
Publicado: (2019) -
Randomized Controlled Trial of a Dose Consolidation Program
por: Delate, Thomas, et al.
Publicado: (2004)